Clinical Trials Directory

Trials / Completed

CompletedNCT02111733

Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Evaluation of High sensibility troponin levels modification by hemodialysis in terminal renal failure patient at Sherbrooke University Hospital Center as determined by serial measurements. Verification of potential effects of these levels and their variation as predictors of cardiovascular outcomes and events at 6 and 12 months.

Detailed description

Recruiting of hemodialysis patients of the nephrology renal supplementation clinics at Sherbrooke University Hospital Center to measure three blood level of high-sensibility troponins before and after standard dialysis. Verification on the variation of these levels after dialysis. Follow-up at 6 and 12 months of the patient for Cardiovascular events and death and verification of a possible predictive value of troponin blood levels for these events.

Conditions

Interventions

TypeNameDescription
OTHERHs-TNT dosageBloodwork before and after hemodialysis for high sensibility troponins T blood level

Timeline

Start date
2013-06-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2014-04-11
Last updated
2014-04-11

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02111733. Inclusion in this directory is not an endorsement.

Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value? (NCT02111733) · Clinical Trials Directory